WILL THE TRADITIONAL MEDICINE UN-PAUSE THE WORLD AND DECIDE THE FATE OF COVID-19? by S. K., JANANI et al.
 
 
   




JANANI S. K.1, DHANABAL S. P.2, SURESHKUMAR R.3*, CHENMALA KARTHIKA4, SAI SURYA NIKITHA 
UPADHYAYULA5 
1,3*,4,5Department of Pharmaceutics, 2
Received: 30 Nov 2020, Revised and Accepted: 12 Jan 2021 
Department of Pharmacognosy and Phytopharmacy, JSS College of Pharmacy, JSS Academy of Higher 
Education and Research, Ooty 643001, The Nilgiris, Tamil Nadu, India 
Email: sureshcoonoor@jssuni.edu.in 
ABSTRACT 
COVID-19 is a life-threatening disease that mainly affects the human respiratory system. In today’s world, scientists are working conscientiously for 
the identification of promising drugs and vaccines. But, when we look back to the former times, herbal medicines were considered for curing most 
of the diseases; luckily, nowadays, natural remedies are being carried forward by few researchers even for the treatment of most life-threatening 
diseases like cancer, diabetes and alzheimer’s etc. So, why can't we attempt the herbal formulation for the management of COVID-19 too? Since 
there is no proper scientific validation for traditional herbs and spices; it just can’t be simply ignored. When a product with less or few side effects 
can be prepared and made available for the benefit of people, there is nothing wrong in pondering them. Thus, keeping these points in mind, in this 
article, we have discussed about SARS CoV-2, their treatment options and the impact of natural remedies on both the former as well as novel 
coronavirus. Further, we have also emphasized on traditional Chinese medicine, various flavonoids and kabasura kudineer and their impact on 
coronavirus infection. Till now, there is no particular drug or vaccine available for the treatment of COVID-19; thus prevention is the only option. 
But, we hope that thorough study; screening, preclinical and clinical evaluation of natural compounds may give some action against SARS CoV-2. 
Moreover, incorporating natural herbs and spices in our diet can help in boosting immunity and fight against various life-threatening diseases.  
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INTRODUCTION 
Currently, most of the people are being affected with the well know 
disease called COVID-19. This disease in recent times has shaken the 
world. SARS-CoV-2 mainly affects the human respiratory system. It 
belongs to the family Coronaviridae that consist of single-stranded 
RNA, a positive sense enveloped in the nucleocapsid [1]. Structure of 
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Fig. 1: Represents the structure of SARSCoV-2: It contains 
positive-stranded RNA (sense) that is enclosed in the 
nucleocapsid, membrane protein, envelop protein and most 
importantly the spike protein (glycoprotein) that binds to the 
receptor present on the human cell [8] 
Since, it is a contagious disease, its outbreak is worst and developing a 
treatment option is also a challenging one. This particular viral 
infection is similar to the former coronavirus infections namely SARS-
CoV (Severe acute respiratory syndrome coronavirus) and MERS-CoV 
(Middle East respiratory syndrome coronavirus). According to the 
National institute of allergy and infectious diseases, SARS-CoV was 
first reported in 2003 in Asia that led to severe viral respiratory 
illness. Followed by MERS-CoV, which is a respiratory disease that was 
first reported in Saudi Arabia in 2012 [2]. In that list, SARS-CoV-2 is 
also a respiratory viral infection that was first originated in Wuhan 
City on 31st
Epidemiology, incubation period and treatment options 
 December 2019. Since then the causative agent for the 
disease was unknown. Thus, they have classified this disease as 
pneumonia with an unknown etiology. However, there is a conjecture 
that it has an animal origin [3]. In this article, we have discussed about 
the virus, its replication cycle and finally, the treatment options. We 
have also shed a light on the traditional medicine and kabasura 
kudineer used in the management of coronavirus infection.  
When we look into epidemiology, countries like India, USA, Russia, 
Iran, Italy, and China are more prone to this disease and the 
mortality rates are also high [4]. According to WHO (World Health 
Organization), the globally confirmed cases are 6,23,63,527 and 
confirmed deaths are 14,56,687 as of 30th
Studies show that the spreading of SARS-CoV-2 is due to person-to-
person transmission. This particular transmission is due to direct 
contact with the affected individual or via the droplets that spread 
through coughing and sneezing from the affected individuals [7]. 
The evolution of virus needs some incubation period. Literature 
state that the mean incubation period is estimated to be 3-7 d 
ranging from 2 to 14 d [8]. However, WHO states that it can range 
from 1-14 d [9]. While coming to the diagnostic tests for COVID-19, 
it includes RT-PCR (reverse-transcription polymerase chain 
reaction), rRt-PCR (real-time reverse transcription PCR) and RT-
LAMP (reverse transcription loop-mediated isothermal 
amplification)[10]. When we look into the treatment options, as of 
 November 2020 [5]. Graph 
representing the case comparison (confirmed cases as of November 
30, 2020) of WHO regions are given in (fig. 2) [6]. 
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now, there is no particular vaccine or drug available for complete 
rehabilitation. However, researchers are putting their effort to find a 
promising solution for this. In that case, various drugs like 
dexamethasone, lopinavir/ritonavir, remdesivir and neuraminidase 
inhibitor including oral oseltamivir and zanamivir [11] are tested 
against COVID-19 but most of them fail to meet the complete 
therapeutic action due to various reasons like the structure of virus, 
toxicity of drug and side effects. However, clinical trials for various 
drugs like decitabine, infliximab and deferoxamine are being carried 
out to find an appropriate medication [12]. 
 
 
Fig. 2: Graph representing the case comparison (confirmed cases as of November 30, 2020) of WHO regions 
 
 
Fig. 3: Represents the replication process of SARS CoV-2 
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Pathophysiology and replication of SARS-CoV-2 
Literatures show that about 70-80% genome of SARS-CoV-2 is similar 
to that of SARS CoV. In addition, the target receptor for both the 
viruses is ACE-2 (Angiotensin-converting enzyme-2), through which 
the SARS-CoV-2 enters into the human cell to cause infection [13]. 
However, the difference in both SARS CoV and SARS-CoV-2 is that the 
SARS-CoV-2 spike binds to the ACE-2 with approximately about 10-20 
fold higher affinity than the SARS CoV, thus making the virus to 
undergo easy replication in the human body. When the SARS-CoV-2 
initially enters into the alveolar epithelial cells, it undergoes 
replication and stimulates a strong immune response which leads to 
cytokine storm syndrome (hypercytokinemia) and pulmonary tissue 
damage. Hypercytokinemia is due to the uncontrolled production of 
pro-inflammatory mediators and plays an important role in acute 
respiratory distress syndrome and failure of multiple organs [8]. 
The replication of SARS-CoV-2 after entering into the human body is 
given in (fig 3). 
Initially, the virus enters the cell by attaching to the ACE-2 receptor 
via endocytosis through a conformational change. After the 
initiation, the sense RNA (+) will be released. This RNA contains a 5′ 
prime and a 3′poly-A tail that will undergo translation. 
 
 
Fig. 4: Represents the formation of RNA (+) and structural protein form the invaded RNA 
 
As given in (fig. 4), the ribosome present in the host cell will 
translate the ORF (open reading frames) to obtain the polyproteins, 
namely pp1a and pp1ab. After the formation of pp1a, there will be a 
frameshift, after which it will lead to the formation of pp1ab. These 
pp1a and pp1ab undergoes proteolysis to form a bunch of proteins, 
namely replicase protein and transcriptase protein that are involved 
in the replication and transcription process. These proteins combine 
with the RNA (+) and leads to the formation of anti-sense RNA via 
replication. The (-) RNA, undergoes a discontinuous transcription to 
form the structural protein as well as replication to form (+) RNA. 
Later, the translation of structural proteins occurs in the 
endoplasmic reticulum. After which, the nucleocapsid, along with 
RNA (+) combines with the ER (intermediate compartment) and gets 
packed into the vesicle. Finally, the matured virion undergoes 
exocytosis and infects other healthy cells [3]. 
Traditional medicines 
Many medicinal plants are available with anti-viral activity. When a 
researcher wants to develop an herbal formulation, it is important to 
understand about its taxonomy, ecology, conservation of herbs and 
the pathways associated with metabolite synthesis [14]. 
Vimalanathan et al. [15] worked on 30 different species of medicinal 
plant to determine the antiviral activity on 7 different viruses like 
herpes simplex virus, mouse coronavirus (a surrogate for human 
SARS virus), influenza virus and sindbis virus etc. In order to check 
the anti-viral activity, they have used 2 different methods, namely 
virucidal and pre-exposure protocol. They have concluded that 
every plant extract had an anti-viral activity to some extent. 
Additionally, the species like Gymnema sylvestre, Pergularia daemia, 
Clitoria ternatea L., Leucas aspera, Cassia alata, Evolvulus alsinoides, 
Vitex trifolia and Clerodendrum inerme had shown an impressive 
result than other extracts. They have stated that the vulnerability of 
mouse coronavirus and influenza virus suggests that these plant 
extracts could also be used in controlling respiratory infections. 
While coming to the Traditional Chinese Medicine (TCM), National 
Health of Commission of China recommends the Chinese medicine 
decoctions [14]. 
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A study has been worked on the evidence for recommending Chinese 
medicine with the help of ancient classics and human studies. They 
have obtained the research evidence data from the clinical trials, 
cohort studies and other population studies using Chinese medicine 
(CM) for preventing communicable respiratory virus diseases. They 
have utilized 3 studies using CM for the prevention of SARS and 4 
studies for H1N1 influenza. For the prevention of COVID-19, 23 
provinces issued CM programme in China. They have counted the 
frequency of the herbs used in the CM formulae in which it has 54 
different herbs out of which 19 were repeated for 3 or more times. The 
top 2 herbs include Radix astragali and Glycyrrhizae Radix Et Rhizoma. 
Finally, they have concluded that based on the historical evidence and 
human evidence of SARS and H1N1 influenza prevention, Chinese 
herbal formula would be an alternative approach for the prevention of 
COVID-19 in the high-risk population [16].  
Li S Y et al., [17] has stated that the extracts from Lycoris radiate, 
Artemisia annua and Lindera aggregate produced anti-viral activity 
against SAR CoV. In addition, the Isatis indigotica root was also tested 
against the SARS CoV. In which, the researcher have checked the anti-
SARS CoV 3C–like protease (chymotrypsin-like protease) effect of 
Isatis indigotica root. As the 3C like protease is responsible for the 
proteolysis of replicase polypeptides 1a and 1ab into a functional 
protein, they have targeted this particular 3C like protease [18].  
A study has been conducted on Torreya nucifera, to find out its 
inhibitory activity on SARS-CoV 3C like protease. The researchers 
have isolated 12 phytochemicals from Torreya nucifera to find out 
their inhibitory action against SARS CoV 3CLpro via the enzymatic 
inhibition assay. From the assay, they have said that the biflavonoid 
amentoflavone had an IC50 value of 8.3µM. Thus, they state this 
particular biflavonoid as a potent inhibitor of SARS CoV 3CLpro
Another study has been done on Houttuynia cordata against the 
SARS CoV. They have tested the effect of Houttuynia cordata for the 
immunomodulatory activity in mouse splenic lymphocytes; they 
have also determined their inhibitory effect on SARS CoV-3CL
 [19].  
pro in 
dose-dependent manner using fluorogenic assay and RNA 
dependent RNA polymerase. As a result, the researcher state that the 
Houttuynia cordata water extract could induce the proliferation of 
splenic lymphocytes in the dose-dependent manner. Through flow 
cytometry, they state that the Houttuynia cordata increased the 
proportion of CD4+, CD8+
From all these studies, we can clearly see that the natural compounds 
can act on the coronavirus in different mechanisms. But all the studies 
that were discussed in the previous session were only for the SARS 
CoV. And as of now, we have seen the effect of Traditional medicine in 
the treatment of SARS CoV infection. While coming to SARS-CoV-2, 
TCM plays a vital role in the treatment. TCM can be an effective 
strategy for the treatment of various syndromes by adjusting the 
specific medicine for each patient. In addition, they can also be used in 
different stages of disease like prevention, treatment and 
rehabilitation. During the outbreak of COVID-19 in China, more than 
3,100 medical staffs of TCM were dispatched to Hubei province [21]. 
Literature shows that the TCM scheme was included in the diagnosis 
and treatment guidelines for COVID-19 as given by the National Health 
Commission and State Administration of Traditional Chinese Medicine 
[21]. Later the TCM experts fully participated in the rescue process 
[22]. They have used decoctions, Chinese patent medicine, 
acupuncture and other therapies for the treatment based on the 
differentiation in the syndrome. 102 cases with mild symptoms 
treated with TCM showed the following parameters:  
T cells [20].  
• The clinical symptom disappearance was shortened by 2 d,  
• The body temperature recovery time was shortened 1.7 d,  
• Stay in the hospital was shortened by 2.2 d,  
• 22% improvement rate in the CT image,  
• 33% increase in the clinical cure rate and  
• 70% increase in the lymphocytes was observed.  
Thus, based on the overall symptoms, they have prescribed the 
prescription like:  
• Qingfei paidu decoction (QPD) 
• Gancaoganjiang decoction 
• Sheganmahuang decoction  
• Qingfei touxie fuzheng recipe etc. 
The QPD has been prescribed for the diagnosis and treatment plan 
of COVID-19 in China. Ren et al. [22] also stated that the effective 
cure rate of QPD against the SARS-CoV-2 was 90%. Through the 
functional enrichment analysis, they have said that the QPD could 
perform activities like inhibition and alleviation of excessive 
immune response and they can eliminate the inflammation through 
the immune-related pathway and cytokine action-related pathway. 
Finally, the author said that the treatment practice of COVID-19 
showed that the early intervention of TCM is important to:  
• Improve the cure rate,  
• Lessen the course of disease,  
• Delay in disease progression and  
• Decrease the mortality rate. 
An article published 2020 on TCM, states that the “Qing Fei Pai Du Tang” 
is screened by the “National Administration of Traditional Chinese 
Medicine” (NATCM) and have widely recommended nationwide. As said 
previously the effect of TCM differs in different stages of disease. Thus, 
before the administration of the treatment, the doctors diagnoses the 
syndrome based on the comprehensive analysis of signs and symptoms. 
This Qing Fei Pai Du Tang contains a total of 21 kinds of Chinese 
Medicines and they say that these compositions were derived from 4 
different prescriptions. 21 herbs are given in (fig. 5) [23]. 
Another work has been carried out on the topic “Prevention and 
treatment of COVID-19 with Qingfei paidu decoction”. They have 
collected data of COVID-19 patients treated with TCM and Qingfei 
paidu decoction in Shanxi, China. They have discussed about the 
efficacy of both TCM as well as the qing fei paidu decoction. It was 
said that qing fei paidu decoction, has a definite curative effect. 
While coming to the efficacy of Qingfei paidu decoction, the author 
has said that out of 76 discharged patients, 59 cases were treated 
with Qingfei paidu decoction and the mean hospitalization time was 
11.3±4.2 d. However, it has been concluded that the clinical efficacy 
of Qingfei paidu decoction needs to be studied further [24]. 
Kai Zhang says that since December 2019, the COVID-19 patients in 
China have been treated with integrated Chinese medicine and western 
medicine. The author says that most of the Chinese herbs can be divided 
into 3 categories like clearing heat, eliminating dampness and 
detoxification. It is given that; Qingfei paidu decoction has been used by 4 
provincial hospitals in China to treat 214 patients with viral infection 
(COVID-19). They have taken 3 d as the course of treatment and the total 
effective rate has reached more than 90%. Despite, in that particular 
study, they say that there were some methodological problems such as 
no control group, no mention about randomization, no blinding study, 
lack of long term efficacy and follow up etc. The author states that high-
quality evidence for the safety of some Chinese herbs are lacking. 
However, it is believed that there are no serious adverse reactions when 
they are used correctly [25]. 
Yang Y et al. [26] says that according to the current clinical guideline 
in China and based on the experience in the treatment of SARS CoV 
and MERS patients, both conventional medicine as well as TCM are 
used in the treatment of SARS-CoV-2. Since the target for the SARS-
CoV-2 entry into the human cell is ACE-2 receptor which is similar to 
that of SARS CoV entry; thus the TCM having the capacity to target 
this receptor will prevent the SARS-CoV-2 infection. The article says 
that on 17th February 2020, National Health Commission (NHC) of 
the People’s Republic of China reported that 60,107 confirmed cases 
of COVID-19 patients had been treated with TCM. Even though the 
author has discussed about the TCM in the treatment of coronavirus; 
finally, they have said that the safety of the TCM used in the 
treatment of emerging coronavirus infections should be carefully 
evaluated in order to avoid toxicity or their interference with the 
efficacy of the conventional treatment methods. 
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Fig. 5: Represents the composition of qingfei pai du tang decoction 
 
Effect of flavonoids and medicinal herb on COVID-19 
Flavonoids are natural compounds that are involved in various 
activities. They usually possess a polyphenolic structure and are 
found commonly in fruits, vegetables and in few beverages as well. 
They produce various health benefits and they are used in various 
nutraceuticals, pharmaceuticals, cosmetics and medicinal 
applications. It can possess various activities like anti-inflammatory, 
anti-oxidant, anti-microbial and anti-viral activities. It has been 
stated that flavonoids like quercetin, naringin, hesperetin and 
catechin possess anti-viral activity by affecting the replication and 
infectivity of certain RNA and DNA [27]. 
Apart from this, the flavonoids has also shown their activity against 
a variety of viruses, including poliovirus, astrovirus, HIV (human 
immunodeficiency virus), enterovirus, respiratory syncytical virus 
(RSV), parainfluenza virus type 3(PIV3), and influenza virus type A 
(Flu A)  
Peterson [28] has worked on in silico modeling to find the binding 
potential of 72 flavonoids towards the main protease (3CLpro) of 
SARS-CoV and SARS CoV-2. The top 10 flavonoids recognized by him 
were amentoflavone, gallocatechin gallate, diosmin, epigallocatechin 
gallate, hidrosmin, catechin gallate, elsamitrucin, pectolinaren, 
quercetin and isoquercetin. 
Furthermore, Adem et al. [29] have worked on natural polyphenols 
to identify the potent inhibitors of COVID-19 main protease with the 
aid of in silico modeling. In this study, they have tested different 
flavonoids to determine their inhibitory action against the main 
protease of SARS-CoV-2. The author has stated that the hesperidin 
showed the highest binding energy at the active site of the COVID-
19. Further, they state that hesperidin and rutin have better binding 
affinity towards the main protease of COVID-19. Hence, they 
conclude that the compounds are dietary foods, they can be 
biologically safe. However, further studies like in vitro and in vivo 
studies are required for the validation of these compounds.  
Vellingiri et al. [30] have discussed about the COVID-19 and the 
current drugs available for their treatment. They have also shed a 
light on the Indian Medicinal plants and their possible effects on the 
COVID-19. In addition, they have stated that AYUSH has 
recommended few Indian medicinal plants as prevention and 
prophylaxis for COVID-19. 
An in silico study has been done by Thuy BT et al., [31] with the aid 
of garlic on SARS CoV-2. They have determined the inhibiting 
capacity of essential garlic oil on ACE-2 as well as on PDB6LU7 
(main protease of SARS-CoV-2). They have identified about 18 
compounds in the essential oil using GC-MS (gas chromatography-
mass spectroscopy). Out of which 17 compounds were having the 
binding abilities. In addition, they state that, diallyl tetrasulfide and 
trisulfide, 2-propenyl propyl had best interaction with regions of 
ACE-2 protein. Finally, it was concluded that the synergistic activity 
of all the 17 compounds have served a good inhibition of both ACE-2 
and PDB6LU7.  
Another in silico study has been carried out by Thirumalaisamy 
Rathinavel; in order to check the effect of 6-gingerol on SARS-CoV-2. 
6-gingerol is a bioactive phenolic phytocompound of ginger. Ginger 
is the herbaceous plant that possesses various activities like anti-
viral, anti-oxidant, antipyretic and analgesic properties. In silico 
studies revealed that 6-gingerol had excellent drug likeliness and 
very good pharmacokinetic properties. In addition, they have stated 
that it also had a high binding affinity of-2.8764 KJ/mol to-15.7591 
KJ/mol with multiple targets of SARS-CoV-2, including viral 
proteases, RNA binding protein and spike protein [32]. 
Apart from the above flavonoids, researchers are also being carried 
out to determine the effect of “Kabasura kudineer” against COVID-
19. Kabasura kudineer are said to be a polyherbal siddha 
formulation that can be used to treat a range of fever irrespective of 
the seasons.  
Pitchiah Kumar et al. [33] worked on kabasura kudineer using in 
silico modeling to target the spike protein of novel coronavirus. They 
have stated that the kabasura kudineer is consisting of 15 herbal 
ingredients. All the ingredients (in Tamil names) along with their 
botanical names are given in the (table 1). 
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Table 1: List of ingredients used in kabasura kudineer 
S. No. Tamil name Botanical name 
1.  Chukku Zingiber Officinale 
2.  Thippili Piper longum 
3.  Kirambu Syzygium aromaticum 
4.  Sirukanchori Tragia involucrate 
5.  Akkirakaram Anacyclus pyrethrum 
6.  Mulliver Hygrophila auriculata 
7.  Kadukkaithol Terminalia chebula 
8.  Adathodai Adathoda vasica 
9.  Karpuravalli Coleus amboinicus 
10.  Kostam Saussurea lappa 
11.  Seendhil Tinospora cordifolia 
12.  Siruthekku Clerodendrum serratum 
13.  Nilavembu Andrographis paniculata 
14.  Vattathiruppi Sida acuta 
15.  Korai kizhangu Cyperus rotundus 
The author has said that according to the rough and accurate docking, the major active phyto compounds that bind with the targets have been 
identified. List of major phytoconstituents are listed in (table 2). 
 
Table 2: Includes the major phytoconstituents that target the spike protein 
S. No. Plant name Phytoconstituent 
1.  Andrographis paniculata Andrographolide 
2.  Hygrophila auriculata Apigenin 
3.  Syzygium aromaticum Carvacrol 
4.  Tragia involucrata Costunolide 
5.  Syzygium aromaticum Eugenol 
6.  Anacyclus pyrethrum Pyrethrin 
7.  Adhatoda vasica Vasicine 
8.  Tinospora cordifolia Cordifolioside B 
9.  Zingiber Officinale Zingiberene 
 
Another study has been carried out by Kiran et al. on Kabasura 
Kudineer with the help of in silico modeling to determine their 
activity against the spike protein of SARS CoV-2. Kabasura kudineer 
and JACOM (a novel drug patented in the year 2018) formulation 
were considered for their study. They have carried out molecular 
docking for 32 phytoconstituents of kabasura kudineer and 5 phyto 
constituents of JACOM. The binding affinity of the compounds 
against the target spike protein has been determined by the LF rank 
score. It was established that chrysoeriol and luteolin from kabasura 
kudineer and quercetin from JACOM formulations were having the 
low LF rank with high binding affinity. Further, in silico 
pharmacokinetic and toxicity studies were studied and as a result 
they have stated that all the phytoconstituents have good oral 
bioavailability and free from toxicity. Further, they have proposed a 
new formulation called SNACK-V containing 9 phytoconstituents 
from 6 herbal plants [34]. 
In addition to the above aspects, Ministry of AYUSH has 
recommended certain Ayurveda’s immunity-boosting measures for 
self-care during the COVID-19 crisis. The recommendations are 
given in (table 3) [36]. Additionally, the meaning response for the 
safety measures has also discussed [37]. As discussed earlier, most 
of the components recommended by AYUSH have several activities 
against viral infections. Thus, the natural herbal compounds can be 
considered for further studies for the management of viral infections 
and diseases. 
  
Table 3: Recommendations made by the ministry of AYUSH 
S. No. Measures Meaning response  
1.  General measures 
(i) Drink warm water throughout the day Seen as cleansing the body 
 (ii) Daily practice of Yogasana, Pranayama and meditation for at least 30 min  Seen to promote physical fitness 
 (iii) Recommended spices like haldi (turmeric), jeera (cumin), dhaniya (coriander) and 
lahsun (garlic) in cooking 
Seen as a health promoter and essential part 
of nutrition 
2.  Ayurvedic immunity promoting measures 
 (i) Taking Chyavanprash of 10 gm Seen as rejuvenating body 
 (ii) Drinking of herbal tea/decoction made of tulsi (basil), dalchini (cinnanmon), 
kalimirch(black pepper), shunthi (dry ginger) and munakka (raisins) once/twice a day 
Seen as a suitable remedy for cough and 
respiratory problems 
 (iii) Uptake of golden milk (made up of turmeric and milk) Seen as fighting against cold and cough 
3.  Simple Ayurvedic procedures 
 (i) Nasal application: Applying of sesame oil or coconut oil or ghee in both the nostrils Seen as a healing substance 
 (ii) Oil pulling therapy: Swishing 1 tablespoon sesame/coconut oil in mouth for 2-3 min Seen as a remedy for various ailments 
4.  Dry cough/Sore throat 
 (i) Steam inhalation with fresh pudina (mint) leaves or ajwain (caraway seeds) Seen as effective against respiratory problems 
 (ii) Uptake of lavang (clove) powder with honey during cough and sore throat Seen as a treatment for the throat diseases 
 
Current scenario and future aspects 
The whole world is now fighting with COVID-19. When a disease is 
not contagious, people no need to worry much. However, when it is 
a communicable disease, it has to be taken into consideration. In the 
current circumstances, scientists from all over the world are putting 
their full effort to develop an effective therapy for rehabilitation. But 
unfortunately, the results aren’t satisfying and successful. The 
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reason for this failure may be due to the pitfalls present during the 
development of drug or vaccine-like side effects, toxicity, multidrug 
resistance, efficacy and so on. Most of the researchers now are 
working on conventional medicine and they had also given satisfying 
results. Even then, we should not forget about our traditional 
medicines. Many traditional medicines are now being forgotten by 
us. However, scientists are working on combination therapy using 
both western as well as traditional medicine. This has also given 
promising results by producing synergistic activity and lessening the 
side effects. Though traditional medicines are giving anticipated 
results, their safety has to be taken into account. For which we need 
to undergo a thorough examination. Besides, we should also 
consider the various aspects of the disease including the symptoms, 
stages and severity in different individuals. However, currently 
clinical trials for traditional medicines in management of COVID-19 
are also being carried out by the researchers [35]. As said by the one 
of the most outstanding fig. in the history of medicine “Let food be 
your medicine and medicine be your food”. Keeping this particular 
quote in mind hope we can wisely fight against various diseases.  
DISCUSSION 
SARS-CoV-2 is a life-threatening disease that emerged from Wuhan, 
China and now it is affecting worldwide. The disease is leading to 
severe outbreaks mainly because of human-to-human transmission. 
The evolution of the infection after entering the human body starts 
once the spike protein (s-protein) binds to the ACE-2 receptor. So, 
researches are being carried out to inhibit this binding. However, 
previous studies have also been carried out for targeting SARS CoV 
3CLpro as they are responsible for the proteolysis of polypeptides 1a 
and 1ab to form functional proteins. Thus, studies are also in 
progress for targeting the 3CLpro
CONCLUSION 
 (chymotrypsin-like protease). As 
discussed earlier, the virus enters into the alveolar epithelial cells 
and stimulates a strong immune response which leads to cytokine 
storm syndrome (hypercytokinemia). This is usually due to the 
uncontrolled production of pro-inflammatory mediators, which can 
lead to a fatal condition. But even this condition can be managed by 
considering the herbal formulation. Because most of the medicinal 
plants have anti-inflammatory properties that have the ability to 
inhibit the production of pro-inflammatory mediators, thus, it may 
help in the management of cytokine storm syndrome. In this article, 
we have discussed about the virus, its replication and few traditional 
medicines involved in the prevention and management of emerging 
coronavirus infection. Mainly we have focused on TCM because they 
are previously involved in treating various diseases like SARS CoV 
and MERS CoV infections. When we look into the literature, the most 
commonly used TCM against SARS-CoV-2 is Qingfei paidu decoction. 
Even though literatures are available for the use of Qingfei paidu 
decoction against COVID-19. Further studies are required to 
understand the clinical efficacy of Qingfei paidu decoction. In 
addition, this type of herbal formulations can be administered to the 
patients only after a thorough understanding of the disease 
symptoms and severity, which will vary from patient to patient. 
Moreover, the TCM has been combined with western medicine in 
some of the studies to get better efficacy. Thus, even though 
literatures are available stating the use of TCM in the management of 
COVID-19, further detailed studies are required to determine their 
safety and efficacy in the treatment of emerging coronavirus. In 
addition, we have also shed a light on Kabasura kudineer and their 
binding affinity by in silico modeling used in the management of 
COVID-19.  
COVID-19 is a life-threatening disease that is affecting most of the 
people around the world in a contagious manner. Even though 
various medications and vaccines are in different stages of 
development, exact remedy for eradicating the COVID-19 are yet to 
be discovered. In that manner, herbal formulations can also be 
considered for the management of SARS CoV-2. Since herbal plants 
possess various medicinal uses and has been used for the treatment 
of various diseases. They can also be considered in the current 
situation. To conclude, traditional medicines can heal various 
diseases irrespective of communicable or non-communicable 
disease. Thus, traditional medicine can be considered for the 
management of novel coronavirus infection as a monotherapy or 
combination therapy after a thorough investigation on their safety, 
efficacy and toxicity etc. 
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